G. Auerswald

1.2k total citations
28 papers, 853 citations indexed

About

G. Auerswald is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, G. Auerswald has authored 28 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 14 papers in Genetics and 2 papers in Surgery. Recurrent topics in G. Auerswald's work include Hemophilia Treatment and Research (24 papers), Platelet Disorders and Treatments (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers). G. Auerswald is often cited by papers focused on Hemophilia Treatment and Research (24 papers), Platelet Disorders and Treatments (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers). G. Auerswald collaborates with scholars based in Germany, Italy and United States. G. Auerswald's co-authors include Massimo Morfini, Elena Santagostino, Víctor Jiménez‐Yuste, Werner Engl, Christoph Bidlingmaier, Karin Kurnik, Birgit M. Reipert, K. Wulff, Arlette Ruiz‐Sàez and F. H. Herrmann and has published in prestigious journals such as Blood, The Journal of Pediatrics and Thrombosis and Haemostasis.

In The Last Decade

G. Auerswald

26 papers receiving 827 citations

Peers

G. Auerswald
G. Auerswald
Citations per year, relative to G. Auerswald G. Auerswald (= 1×) peers Mónica Martín‐Salces

Countries citing papers authored by G. Auerswald

Since Specialization
Citations

This map shows the geographic impact of G. Auerswald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Auerswald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Auerswald more than expected).

Fields of papers citing papers by G. Auerswald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Auerswald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Auerswald. The network helps show where G. Auerswald may publish in the future.

Co-authorship network of co-authors of G. Auerswald

This figure shows the co-authorship network connecting the top 25 collaborators of G. Auerswald. A scholar is included among the top collaborators of G. Auerswald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Auerswald. G. Auerswald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mackensen, Sylvia von, Ronald Fischer, Susan Halimeh, et al.. (2025). Health‐Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL‐QoL Study. Haemophilia. 32(1). 143–154.
2.
Halimeh, Susan, C. Wermes, Ronald Fischer, et al.. (2025). Clinical, Obstetric‐Gynaecological and HRQoL Data of Female VWD Patients in the WIL‐QoL Study. Haemophilia. 32(1). 174–184.
3.
Peyvandi, Flora, G. Auerswald, Steve Austin, et al.. (2021). Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency. Blood Reviews. 50. 100833–100833. 14 indexed citations
5.
Auerswald, G., Claudia Djambas Khayat, Oleksandra Stasyshyn, et al.. (2020). <p>Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)</p>. Journal of Blood Medicine. Volume 11. 213–225. 6 indexed citations
6.
Walsh, Christopher, G. Auerswald, Salvador Grancha, & Víctor Jiménez‐Yuste. (2016). The burden of inhibitors in haemophilia patients. Thrombosis and Haemostasis. 116(S 01). S10–S17. 50 indexed citations
7.
Auerswald, G., Alexis A. Thompson, Michael Recht, et al.. (2012). Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A. Thrombosis and Haemostasis. 107(6). 1072–1082. 35 indexed citations
8.
Young, Guy, G. Auerswald, Víctor Jiménez‐Yuste, et al.. (2012). PRO-PACT: Retrospective observational study on the prophylactic use of recombinant factor VIIa in hemophilia patients with inhibitors. Thrombosis Research. 130(6). 864–870. 38 indexed citations
9.
Young, Guy, G. Auerswald, Víctor Jiménez‐Yuste, et al.. (2011). When should prophylaxis therapy in inhibitor patients be considered?. Haemophilia. 17(5). e849–57. 27 indexed citations
10.
Kurnik, Karin, et al.. (2009). New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development. Haemophilia. 16(2). 256–262. 126 indexed citations
11.
Mariani, Guglielmo, Angelika Bátorová, Alberto Dolce, et al.. (2009). Replacement Therapy for Surgery in FVII Deficiency: The Ster Experience Concerning 63 Interventions.. Blood. 114(22). 1290–1290. 1 indexed citations
13.
Morfini, Massimo, G. Auerswald, Rainer Kobelt, et al.. (2007). Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres. Haemophilia. 13(5). 502–507. 63 indexed citations
14.
Herrmann, F. H., G. Auerswald, Arlette Ruiz‐Sàez, et al.. (2006). Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene. Haemophilia. 12(5). 479–489. 143 indexed citations
15.
Konkle, Barbara A., Liselotte S. Ebbesen, G. Auerswald, et al.. (2006). Secondary Prophylaxis with rFVIIa Improves Quality of Life of Hemophilia Patients with Inhibitors and Frequent Bleeds.. Blood. 108(11). 1028–1028. 2 indexed citations
16.
Nemes, László, Toshko Lissitchkov, Anna Klukowska, et al.. (2006). Evaluation of pharmacokinetics, efficacy and safety of Immunate® solvent detergent in previously treated patients with severe haemophilia A. Haemophilia. 13(1). 9–11. 10 indexed citations
17.
Herrmann, Falko H., et al.. (2005). Homozygous Factor X gene mutations Gly380Arg and Tyr163delAT are associated with perinatal intracranial hemorrhage. The Journal of Pediatrics. 146(1). 128–130. 14 indexed citations
19.
Kreuz, W., G. Auerswald, Ulrich Budde, & H. Lenk. (2004). Inhibitor Incidence in Previously Untreated Patients (PUP) with Hemophilia A and B - a 10-Year-Follow up of the Prospective Multicenter Study.. Blood. 104(11). 3983–3983. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026